Interim Analysis of a Phase II Clinical Trial of Induction Gemcitabine/Capecitabine followed by SABR in Borderline/Locally Advanced Pancreatic Adenocarcinoma

Authors :: Malolan S. Rajagopalan
Ronald G. Stoller
Nathan Bahary
Herbert J. Zeh
Rodney E. Wegner
Steven A. Burton
J.C. Flickinger
D.A. Clump
Dwight E. Heron
Kimmen Quan
Barry C. Lembersky
Source :: International Journal of Radiation Oncology*Biology*Physics. 90:S48-S49
Publication Year :: 2014
Publisher :: Elsevier BV, 2014.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Radiation
business.industry
Locally advanced
Interim analysis
medicine.disease
SABR volatility model
Gemcitabine
Capecitabine
Clinical trial
Internal medicine
Medicine
Adenocarcinoma
Radiology, Nuclear Medicine and imaging
business
medicine.drug

Full Text Access

Tools